Evaluation of the performance of a new serum amyloid A chemiluminescence immunoassay

Objective: Serum amyloid A (SAA) is a protein involved in the acute phase of inflammation. SAA expression is upregulated in humans during the acute phase of various viral infections; in addition, SAA can be a useful biomarker to predict the severity and prognosis of COVID-19 patients. This study aim...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Martina Pelagalli, Flaminia Tomassetti, Serena Sarubbi, Eleonora Nicolai, Alfredo Giovannelli, Francesco Turis, Camilla Illuminati, Maria Morello, Cinzia Callà, Alessandro Terrinoni, Sergio Bernardini, Massimo Pieri
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-09-01
Saila:	LabMed Discovery
Gaiak:	Serum amyloid A (SAA) Inflammation Method validation Automation Clinical laboratory C-reactive protein (CRP)
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S3050474025000394
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!